Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
May 06, 2024 11:16 ET
|
Achieve Life Sciences
Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo Cytisinicline treatment well tolerated with no serious adverse events...
SECU Foundation Awards MemoryCare $250,000 to Expand Dementia Care in Rural Western North Carolina
May 06, 2024 10:37 ET
|
State Employees' Credit Union (SECU)
SECU Foundation awarded $250,000 to MemoryCare for the expansion of dementia care and in-home clinical and care management services in rural Western N.C.
Phlow Corp. Appoints General Gustave F. Perna to the Phlow Business Advisory Board
May 06, 2024 09:29 ET
|
Phlow Corp.
Richmond, VA, May 06, 2024 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based certified B Corporation leveraging advanced development and manufacturing processes to re-imagine the domestic production of...
Red Pine Provides Update On Assay Results for Wawa Gold Project
May 06, 2024 09:09 ET
|
Red Pine Exploration Inc.
TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”), further to its press release of May 1, 2024 (the “Prior Press Release”),...
Inmagene Reports Positive Interim Results from Phase 2a Trial of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Atopic Dermatitis
May 06, 2024 09:00 ET
|
Inmagene Biopharmaceuticals
Treatment with IMG-007, the only clinical-stage nondepleting anti-OX40 monoclonal antibody (mAb), led to rapid, marked, and durable improvement of skin signs in patients with atopic dermatitis...
Nayax to Exhibit its Leading Payment and Vending Management Technology at The NAMA Show 2024
May 06, 2024 08:30 ET
|
Nayax Ltd.
Visit Nayax at Booth 1542 at The NAMA Show on May 7-9 in Dallas, TX.
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
May 06, 2024 08:15 ET
|
Belite Bio, Inc
Webinar, moderated by Cantor Fitzgerald, will be held on Monday, May 13, 2024, at 2:00 p.m. ET Discussion will feature Dr. Michel Michaelides, leading expert in the field of inherited eye disease...
The American Nurses Association Lights up Buildings Across the United States for Nurses Week
May 06, 2024 08:04 ET
|
American Nurses Association
SILVER SPRING, MD, May 06, 2024 (GLOBE NEWSWIRE) -- Kicking off Nurses Week, the American Nurses Association (ANA) is lighting up over 50 city skylines, landmarks, and participating hospitals across...
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
May 06, 2024 08:00 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
May 06, 2024 08:00 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...